Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Halperin

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Journal of the American College of Cardiology|January 1, 1985
Effect of nitroglycerin on the pulmonary venous gradient in patients after mitral valve replacementJ L Halperin, K M Brooks, E B Rothlauf, et al.
Journal of the American College of Cardiology|January 15, 2000
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation InvestigatorsR G Hart, L A Pearce, R M Rothbart, et al.
Stroke|April 3, 1999
Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implicationsJ L Blackshear, L A Pearce, R G Hart, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 10, 1999
Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study)M E Goldman, L A Pearce, R G Hart, et al.
The American Journal of Cardiology|November 1, 1982
Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failureJ L Halperin, D P Faxon, M A Creager, et al.
Circulation|September 1, 1981
Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failureM A Creager, J L Halperin, D B Bernard, et al.
American Heart Journal|November 1, 1982
Determinants of clinical response and survival in patients with congestive heart failure treated with captoprilM A Creager, D P Faxon, J L Halperin, et al.
The American Journal of Cardiology|October 1, 1993
Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation InvestigatorsJ L Blackshear, L A Pearce, R W Asinger, et al.
Chest|February 7, 2001
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safetyJ Hirsh, T E Warkentin, S G Shaughnessy, et al.
Journal of Thrombosis and Haemostasis : JTH|September 26, 2012
Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?A C Spyropoulos, N A Goldenberg, C M Kessler, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of the American College of Cardiology|January 1, 1985
Effect of nitroglycerin on the pulmonary venous gradient in patients after mitral valve replacementJ L Halperin, K M Brooks, E B Rothlauf, et al.
Journal of the American College of Cardiology|January 15, 2000
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation InvestigatorsR G Hart, L A Pearce, R M Rothbart, et al.
Stroke|April 3, 1999
Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implicationsJ L Blackshear, L A Pearce, R G Hart, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 10, 1999
Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study)M E Goldman, L A Pearce, R G Hart, et al.
The American Journal of Cardiology|November 1, 1982
Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failureJ L Halperin, D P Faxon, M A Creager, et al.
Circulation|September 1, 1981
Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failureM A Creager, J L Halperin, D B Bernard, et al.
American Heart Journal|November 1, 1982
Determinants of clinical response and survival in patients with congestive heart failure treated with captoprilM A Creager, D P Faxon, J L Halperin, et al.
The American Journal of Cardiology|October 1, 1993
Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation InvestigatorsJ L Blackshear, L A Pearce, R W Asinger, et al.
Chest|February 7, 2001
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safetyJ Hirsh, T E Warkentin, S G Shaughnessy, et al.
Journal of Thrombosis and Haemostasis : JTH|September 26, 2012
Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?A C Spyropoulos, N A Goldenberg, C M Kessler, et al.
Pageof 8